The global chagas disease management market was valued at USD 5.72 Mn in 2021 and is expected to witness a CAGR of 7.6% over the forecast period 2022-2028. Chagas disease is a kinetoplastid protozoan parasite transmitted by Trypanosoma cruzi that is largely spread by huge, blood-sucking reduviid insects known as "kissing bugs" in 21 Latin American nations. In addition, the disease can be spread through various methods such as blood transfusion, organ transplantation, congenital, and oral transmissions. Owing to movement of people from Latin America to other nations, Chagas disease has recently spread to developed economies such as Europe and North America. According to a report released in the National Center for Biotechnology Information (NCBI), Chagas disease afflicted 4.2 percent of Latin Americans living in European countries in 2015. Only benznidazole has been approved by the FDA for the treatment of Chagas disease.

View detailed report description here https://precisionbusinessinsights.com/market-reports/chagas-disease-management-market/

The number of people suffering with chagas illness is rising over the world. The main causes of this predicament are filthy environments and a growing global population. The chagas disease treatment market is growing as a result of these causes. Aside from that, the market is projected to see new companies enter and innovative technologies for the treatment of Chagas disease develop. Several competitors in the chagas disease therapy market have been boosting their research efforts in recent years. The development of novel therapeutic options for chagas disease is the primary motivation for this move. Furthermore, a number of vendors have received authorisation for the launch of new items. The market for chagas disease therapy is growing as a result of these causes. During the forecast period of 2019 to 2027, however, some factors are expected to hamper the expansion of the chagas disease treatment market. The need for increased knowledge about chagas disease therapy, the current market's limited number of approved medicines, and supply chain challenges with chagas disease drugs are some of the important concerns that market players will need to focus on in the next years.

The global chagas disease management market segmentation:

By Treatment Type (Antiparasitic treatment, Symptomatic treatment),

By Drug Type (Benznidazole, Nifurtimox),

By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online Pharmacies

Owing to the increased research and development expenditures, an increase in the number of patients, and a favourable reimbursement environment in this region, North America dominates the chagas disease treatment market. For the forecast period, Asia-Pacific is expected to have the fastest growth rate and the highest CAGR. This is due to expanding government spending on healthcare infrastructure, growing government attempts to raise awareness, as well as rising personal disposable income.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=15817                                                                                   

Some of the major key players in the Chagas Disease Management Market are AstraZeneca (U.K) Bayer AG (Germany) Daiichi Sankyo Company Ltd (Japan) Eisai Co Ltd (Japan) GlaxoSmithKline Plc. (U.K) Grupo Praxis Pharmaceutical SA (Spain) KaloBios Pharmaceuticals, Inc. (U.S.) Kancera AB (Sweden) Novartis AG (Switzerland) Laboratorio Elea S.A.C.I.F. y A (Argentina) Oblita Therapeutics BVBA (Belgium) Sanofi (France)

Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747